|Church Street Trustees||-|
|ESSEC Ventures||Cergy-pontoise, France, Ile-de-France|
|Gordon Asset Management||-|
|Heihe asset management||-|
|Massa Innovations||England, London, United Kingdom|
|Medicxi Ventures||England, London, United Kingdom|
|Morgan Creek Digital||Chapel Hill, North Carolina, United States|
|Morgan Stanley Capital Partners||New York, New York, United States|
|Nifco||England, Stockton-on-Tees, United Kingdom|
|Orca Capital||China, Shanghai|
|Palm Beach Capital||Florida, United States, West Palm Beach|
|Pintu Media||Beijing, Beijing, China|
|Piper Sandler||Aberdeen, Scotland, United Kingdom|
|Sigma Capital Group||City of Edinburgh, Scotland, United Kingdom|
|Zhuhaishi Tongxin Touzi Co., Ltd||China, Guangdong, Zhuhai|
|$45M||29 Sep 2022||New York, New York, United States|
|$20M||08 Sep 2022||New York, New York, United States|
|$24M||23 Aug 2022||Denver, Colorado, United States|
|$33M||02 Aug 2022||Sewickley, Pennsylvania, United States|
|$72M||06 Jul 2022||Corona Del Mar, California, United States|
|$106M||13 Jun 2022||New York, New York, United States|
|$23M||09 Jun 2022||New York, New York, United States|
|$9M||31 Mar 2022||Washington, District of Columbia, United States|
|$55M||01 Mar 2022||New York, New York, United States|
– TMRW Life Sciences, Inc., a NYC-based life sciences technology company providing an automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization (IVF), completed a $105m Series C equity and debt financing.
– The equity round was led by Transformation Capital with participation from GV (formerly Google Ventures), Casdin Capital, Peter Thiel, Anne and Susan Wojcicki, and existing investors 5AM Ventures and Life Sciences Innovation Fund, among others.
– The company intends to use the funds to accelerate global expansion, advance product innovation, develop consumer awareness of the platform, and support future business development opportunities.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.